Health Condition 1: K929- Disease of digestive system, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with clinical features of Grahani Roga 2.Patients diagnosed with IBS, based on Rome IV criteria or a similar standard diagnostic guideline 3.Inclusion of specific IBS subtypes IBS-D (diarrhoea predominant) 4.Patients with mild to moderate IBS severity, measured by a validated scale of IBS Severity Scoring System (IBS-SSS) 5.Patients willing to participate in the study
Exclusion criteria
Exclusion criteria: 1.Individuals with severe IBS symptoms that may require immediate medical intervention 2.Pregnant or breastfeeding women 3.Patients with other GI diseases (e.g., inflammatory bowel disease, celiac disease, colorectal cancer) 4.Severe psychiatric illnesses (e.g., major depression, schizophrenia) 5.Patients with diabetes, cardiovascular disorders, thyroid and renal diseases or any other systemic diseases 6.Patients already following specific diets (e.g., low FODMAP, gluten-free) 7.Recent use of antibiotics or probiotics within the past 4-6 weeks 8.Participants enrolled in any other clinical trials that may affect outcomes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected Reduction in Symptoms Severity Scale, BMITimepoint: Follow up of patients of all 3 groups will be done at an interval of every one month, for total study period of 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected Improvement in Quality of Life, Perceived Stress Scale, Agni BalaTimepoint: Follow up of patients of all 3 groups will be done at an interval of every one month, for total study period of 3 months | — |
Countries
India
Contacts
Banaras Hindu University Varanasi